
Nidipine SR20 mg
Square Pharmaceuticals PLC.
Nifedipine is a dihydropyridine calcium channel blocker used for the following indications: Established / FDA-approved uses Hypertension (extended-release formulation only) — used alone or in…
Nifedipine is a dihydropyridine calcium channel blocker used for the following indications:
Note: Immediate-release Nifedipine capsules are not indicated, and should not be used, for treatment of hypertension or hypertensive emergencies (see Precautions and Warnings).
Dosage of Nifedipine should be individualized by a physician based on indication, response, and tolerability.
| Indication | Formulation | Typical Adult Dosage |
|---|---|---|
| Hypertension | Extended-release tablet | Initially 30–60 mg once daily; usual maintenance range 30–90 mg once daily. Maximum dose varies by brand (typically 90–120 mg/day); do not exceed the labeled maximum for the specific product. |
| Chronic stable angina | Extended-release tablet | 30–60 mg once daily, titrated over 7–14 days; maximum typically 90–120 mg/day depending on product. |
| Chronic stable / vasospastic angina | Immediate-release capsule | Initially 10 mg three times daily; usual range 10–20 mg three times daily; maximum 180 mg/day. Not recommended for routine use due to safety concerns (see Precautions and Warnings). |
| Preterm labor tocolysis (off-label) | Immediate-release capsule/tablet | Per obstetric protocol only, e.g. an initial loading dose followed by a lower maintenance dose for up to approximately 48 hours; must be prescribed and monitored by an obstetric specialist. |
No specific dose adjustment is generally required for renal impairment, though patients should be monitored. In hepatic impairment, Nifedipine clearance is reduced; a lower starting dose and careful monitoring are recommended.
Seek prompt medical attention for signs of a serious reaction, such as chest pain, fainting, marked swelling, or difficulty breathing, while taking Nifedipine.
Immediate-release Nifedipine should not be used for treating hypertensive emergencies (see Precautions and Warnings) — this is a formulation-specific restriction rather than a hypersensitivity-type contraindication.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.